冀衡医药(002742)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002742 冀衡医药

已收盘 09-14 15:00:00

{"stockData":{"symbol":"002742","market":"SZ","secType":"STK","nameCN":"冀衡医药","latestPrice":4.23,"timestamp":1789369389000,"preClose":4.25,"halted":0,"volume":26841900,"delay":0,"changeRate":-0.0047,"floatShares":524000000,"shares":684000000,"eps":-0.4515,"marketStatus":"已收盘","change":-0.02,"latestTime":"09-14 15:00:00","open":4.29,"high":4.31,"low":4.17,"amount":114000000,"amplitude":0.0329,"askPrice":4.23,"askSize":1526,"bidPrice":4.22,"bidSize":1046,"shortable":0,"etf":0,"ttmEps":-0.4515,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":4.25,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":4.68,"lowLimit":3.83,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":684102041,"isCdr":false,"pbRate":19.61,"roa":"--","roe":"--","epsLYR":-0.61,"committee":0.369581,"marketValue":2894000000,"turnoverRate":0.0512,"status":1,"floatMarketCap":2216000000},"requestUrl":"/m/hq/s/002742","defaultTab":"news","newsList":[{"id":"2665081311","title":"冀衡医药（002742）披露股票交易异常波动公告，9月7日股价上涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665081311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665081311?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:44","pubTimestamp":1788774298,"startTime":"0","endTime":"0","summary":"截至2026年9月7日收盘，冀衡医药报收于4.55元，较前一交易日上涨6.31%，最新总市值为31.13亿元。该股当日开盘4.44元，最高4.58元，最低4.44元，成交额达4.04亿元，换手率为17.05%。公司于2026年9月7日发布《股票交易异常波动公告》。公告显示，冀衡医药股票于2026年9月2日至9月4日连续三个交易日收盘价跌幅偏离值累计达21.26%，属于股票交易异常波动。公司不存在违反信息公平披露的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002742","BK0028","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665436129","title":"冀衡医药(002742.SZ)股价异动 不存在应披露而未披露信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2665436129","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665436129?lang=zh_cn&edition=full","pubTime":"2026-09-06 16:27","pubTimestamp":1788683221,"startTime":"0","endTime":"0","summary":"格隆汇9月6日丨冀衡医药公告，重庆冀衡医药股份有限公司股票日收盘价格涨跌幅偏离值累计异常，2026年9月2日、2026年9月3日、2026年9月4日，连续3个交易日收盘价跌幅偏离值累计达到21.26%。根据《深圳证券交易所交易规则》的有关规定，属于股票交易异常波动情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260906/32361231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0132","002742","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664995873","title":"9月3日冀衡医药（002742）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2664995873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664995873?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:40","pubTimestamp":1788428454,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月3日公布的交易公开信息显示，冀衡医药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第5次上榜。截至2026年9月3日收盘，冀衡医药报收于4.53元，下跌9.94%，已连续跌停2天，换手率19.53%，成交量102.35万手，成交额4.73亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300032136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002742","BK0235","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664214890","title":"9月2日冀衡医药（002742）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2664214890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664214890?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:32","pubTimestamp":1788341573,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月2日公布的交易公开信息显示，冀衡医药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第4次上榜。截至2026年9月2日收盘，冀衡医药报收于5.03元，下跌10.02%，跌停，换手率19.23%，成交量100.73万手，成交额5.18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200031276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0235","BK0028","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079468","title":"8月31日冀衡医药（002742）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663079468?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:38","pubTimestamp":1788169105,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月31日公布的交易公开信息显示，冀衡医药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年8月31日收盘，冀衡医药报收于5.62元，下跌9.94%，跌停，换手率4.7%，成交量24.6万手，成交额1.38亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100024261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0132","BK0235","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662354069","title":"8月28日冀衡医药（002742）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2662354069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662354069?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:58","pubTimestamp":1787911126,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月28日公布的交易公开信息显示，冀衡医药因日涨幅偏离值达到7%的前5只证券，日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年8月28日收盘，冀衡医药报收于6.24元，上涨10.05%，已连续涨停4天，换手率41.97%，成交量219.9万手，成交额13.45亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0132","BK0235","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662570529","title":"冀衡医药（002742）披露股票交易异常波动公告，8月27日股价上涨10.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662570529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662570529?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:24","pubTimestamp":1787826278,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，冀衡医药报收于5.67元，较前一交易日上涨10.1%，最新总市值为38.79亿元。该股当日开盘5.67元，最高5.67元，最低5.67元，成交额达5642.27万元，换手率为1.9%。公司于近日披露《股票交易异常波动公告》，称其股票于2026年8月25日、8月26日连续两个交易日收盘价涨幅偏离值累计达到20.35%，构成股票交易异常波动。公司董事会确认无应披露未披露事项，且不存在违反信息公平披露的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700044442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002742","BK0235","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792956","title":"8月26日冀衡医药（002742）龙虎榜数据：机构净卖出878.17万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792956","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662792956?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:53","pubTimestamp":1787737985,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月26日公布的交易公开信息显示，冀衡医药因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月26日收盘，冀衡医药报收于5.15元，上涨10.04%，已连续涨停2天，换手率2.46%，成交量12.87万手，成交额6628.66万元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出878.17万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600040603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0028","BK0132","002742"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660876108","title":"股市必读：冀衡医药中报 - 第二季度单季净利润同比增长75.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660876108","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660876108?lang=zh_cn&edition=full","pubTime":"2026-08-17 03:13","pubTimestamp":1786907591,"startTime":"0","endTime":"0","summary":"股本股东变化：截至2026年7月31日股东户数为1.6万户，较6月30日增加5.98%。业绩披露要点：2026年上半年归母净利润为-2013.85万元，同比上升84.62%；第二季度单季度归母净利润-1206.52万元，同比上升75.18%。公司公告汇总：第六届董事会第五次会议于2026年8月14日审议通过《关于公司2026年半年度报告及报告摘要的议案》，表决结果为全票通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179552","title":"冀衡医药（002742）2026年中报简析：亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659179552?lang=zh_cn&edition=full","pubTime":"2026-08-16 06:05","pubTimestamp":1786831551,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期冀衡医药发布2026年中报。根据财报显示，冀衡医药亏损收窄。其中，毛利率12.1%，同比减40.69%，净利率-8.61%，同比增68.09%，销售费用、管理费用、财务费用总计3801.79万元，三费占营收比15.79%，同比减62.18%，每股净资产0.22元，同比增117.03%，每股经营性现金流-0.1元，同比减691.05%，每股收益-0.03元，同比增90.3%证券之星价投圈财报分析工具显示：业务评价：去年的净利率为-50.99%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600001377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0028","BK0132","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659839140","title":"冀衡医药（002742）披露2026年半年度报告，8月14日股价下跌1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659839140","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659839140?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:35","pubTimestamp":1786718118,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，冀衡医药报收于4.27元，较前一交易日下跌1.84%，最新总市值为29.21亿元。该股当日开盘4.35元，最高4.53元，最低4.23元，成交额达9032.7万元，换手率为3.98%。近日，冀衡医药披露《2026年半年度报告》。本报告期末总资产为1,095,343,325.32元，较上年度末的1,195,759,012.89元下降8.40%；归属于上市公司股东的净资产为148,242,087.28元，较上年度末的168,380,544.20元下降11.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400040723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0132","002742","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659614562","title":"冀衡医药(002742.SZ)发布上半年业绩，归母净亏损2013.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659614562","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659614562?lang=zh_cn&edition=full","pubTime":"2026-08-14 19:14","pubTimestamp":1786706074,"startTime":"0","endTime":"0","summary":"智通财经APP讯，冀衡医药(002742.SZ)发布2026年半年度报告，报告期内，公司实现营业收入2.41亿元，同比下降50.51%。归属于上市公司股东净亏损2013.85万元，归属于上市公司股东的扣除非经常性损益净亏损1983.51万元，基本每股亏损0.0294元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","002742","BK0028","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659897110","title":"图解冀衡医药中报：第二季度单季净利润同比增长75.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659897110","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659897110?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:40","pubTimestamp":1786700448,"startTime":"0","endTime":"0","summary":"证券之星消息，冀衡医药2026年中报显示，上半年度公司主营收入2.41亿元，同比下降50.51%；归母净利润-2013.85万元，同比上升84.62%；扣非净利润-1983.51万元，同比上升84.37%；其中2026年第二季度，公司单季度主营收入9881.57万元，同比下降60.7%；单季度归母净利润-1206.52万元，同比上升75.18%；单季度扣非净利润-1138.66万元，同比上升75.3%；负债率80.05%，投资收益-126.66万元，财务费用875.8万元，毛利率12.1%。财报数据概要请见下图:本文数据来源于冀衡医药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400029864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117247","title":"冀衡医药(002742)7月31日股东户数1.6万户，较上期增加5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117247","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659117247?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:31","pubTimestamp":1786699912,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冀衡医药披露，截至2026年7月31日公司股东户数为1.6万户，较6月30日增加903.0户，增幅为5.98%。在化学制药行业个股中，冀衡医药股东户数低于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.61万户。从股价来看，2026年6月30日至2026年7月31日，冀衡医药区间涨幅为4.48%，在此期间股东户数增加903.0户，增幅为5.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400029578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0028","BK0235","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658099977","title":"冀衡医药：截至2026年7月31日，公司股东数为15,995户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658099977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658099977?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:48","pubTimestamp":1786538900,"startTime":"0","endTime":"0","summary":"证券之星消息，冀衡医药(002742)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到7月31日公司股东人数是多少？谢谢冀衡医药回复：尊敬的投资者，截至2026年7月31日，公司股东数为15,995户，感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200037916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0235","002742","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654064250","title":"股市必读：冀衡医药（002742）7月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2654064250","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654064250?lang=zh_cn&edition=full","pubTime":"2026-07-27 02:30","pubTimestamp":1785090633,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，冀衡医药报收于3.27元，下跌3.82%，换手率1.26%，成交量6.58万手，成交额2167.16万元。董秘最新回复投资者： 董秘，你好！重组计划承诺2026年冀衡集团对冀衡医药支持2亿元用生产升级及闲置资产利用，已经快进入8月份了，不知道这2亿元用的怎么样，是否已经开始投入使用？目前，控股股东已向公司全资子公司提供了5000万元的低息借款支持其生产经营，感谢关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700001186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0235","BK0132","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653082744","title":"冀衡医药：控股股东已提供5000万元低息借款","url":"https://stock-news.laohu8.com/highlight/detail?id=2653082744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653082744?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:52","pubTimestamp":1784897562,"startTime":"0","endTime":"0","summary":"证券之星消息，冀衡医药(002742)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，你好！重组计划承诺2026年冀衡集团对冀衡医药支持2亿元用生产升级及闲置资产利用，已经快进入8月份了，不知道这2亿元用的怎么样，是否已经开始投入使用？冀衡医药回复：尊敬的投资者，根据《重整计划》，公司控股股东3年内将通过股东借款、非公开发行等方式为公司提供不少于2亿元现金流支持。目前，控股股东已向公司全资子公司提供了5000万元的低息借款支持其生产经营，感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0235","BK0132","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651448560","title":"股市必读：冀衡医药（002742）预计2026年1-6月扣非后净利润亏损1800万元至2300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651448560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651448560?lang=zh_cn&edition=full","pubTime":"2026-07-15 02:42","pubTimestamp":1784054531,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，冀衡医药报收于3.59元，上涨1.41%，换手率1.7%，成交量8.9万手，成交额3153.85万元。业绩披露要点业绩预告冀衡医药发布业绩预告，预计2026年1-6月扣非后净利润亏损1800万元至2300万元；归属净利润亏损1800万元至2300万元；每股收益亏损0.029元至0.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651047511","title":"冀衡医药（002742）披露2026年半年度业绩预告，7月14日股价上涨1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651047511","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651047511?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:38","pubTimestamp":1784039894,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，冀衡医药报收于3.59元，较前一交易日上涨1.41%，最新总市值为24.56亿元。该股当日开盘3.52元，最高3.6元，最低3.45元，成交额达3153.85万元，换手率为1.7%。公告显示，公司预计2026年上半年归属于上市公司股东的净利润为-2,300万元至-1,800万元，较上年同期亏损大幅收窄。相关财务数据未经会计师事务所审计，最终数据以2026年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002742","BK0235","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646735684","title":"冀衡医药：6月26日副总经理高序英增持股份合计5.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646735684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646735684?lang=zh_cn&edition=full","pubTime":"2026-06-26 18:01","pubTimestamp":1782468089,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月26日市场公开信息、上市公司公告及交易所披露数据整理，冀衡医药（002742）最新董监高及相关人员股份变动情况：2026年6月26日公司副总经理高序英共增持公司股份5.2万股，占公司总股本为0.0076%。变动期间公司股价下跌4.12%，6月26日当日收盘报3.26元。冀衡医药近半年内的董监高及核心技术人员增减持详情如下：冀衡医药的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、冀衡医药公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002742","BK0132","BK0235","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789377347623,"stockEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0363},{"period":"3month","weight":0.0192},{"period":"6month","weight":-0.0721},{"period":"1year","weight":-0.0936},{"period":"ytd","weight":-0.0597}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆冀衡医药股份有限公司","boardCode":"AI0030","boardName":"非金属矿物制品业","stockholders":"15995人(较上一季度增加5.98%)","perCapita":"32755股","listingDate":"2015-02-17","address":"重庆市北碚区三圣镇街道","registeredCapital":"68410万元","survey":"　　重庆冀衡医药股份有限公司的主营业务是医药制造业务。公司的主要产品是医药中间体、原料药、制剂产品。","listedPrice":20.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"冀衡医药(002742)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供冀衡医药(002742)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"冀衡医药,002742,冀衡医药股票,冀衡医药股票老虎,冀衡医药股票老虎国际,冀衡医药行情,冀衡医药股票行情,冀衡医药股价,冀衡医药股市,冀衡医药股票价格,冀衡医药股票交易,冀衡医药股票购买,冀衡医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"冀衡医药(002742)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供冀衡医药(002742)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}